Narcotic Drugs Market Growth To $18.78 Billion By 2030: What’s Driving The Expansion?
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Narcotic Drugs Market Size, Value And Growth Trajectory Through 2030
The narcotic drugs market size has demonstrated consistent expansion in recent years. It is projected to escalate from $14.71 billion in 2025 to $15.32 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.2%. This historical growth was influenced by the increasing prevalence of chronic pain, widespread opium cultivation, a rising incidence of cancer-related pain, the traditional reliance on hospital pharmacies, and a high prevalence of cough and diarrhea conditions.
The market for narcotic drugs is projected to experience robust expansion over the coming years. By 2030, its value is forecast to reach $18.79 billion, demonstrating a compound annual growth rate (CAGR) of 5.2%. This projected increase is largely due to factors such as a heightened demand for abuse-deterrent formulations, the proliferation of online pharmacy channels, breakthroughs in synthetic narcotics production, an elevated emphasis on individualized pain management, and a rise in regulatory approvals for novel narcotic medications. Key trends anticipated during this period encompass the increase in prescription drug monitoring programs, the evolution of pain management therapies, the wider adoption of abuse-deterrent formulations, the growth of specialty pharmacies, and ongoing development in synthetic narcotics.
Get A Free Sample Report With In-Depth Market Insights:
Narcotic Drugs Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The narcotic drug market is projected to expand due to the increasing occurrence of chronic diseases. A chronic disease is an illness lasting three months or longer that can deteriorate over time. Narcotic drugs are utilized to manage chronic conditions, offering relief for issues like cancer, chronic pain syndrome, terminal illness, and severe arthritis. For instance, in June 2024, data from the National Health Service, a UK-based government department, revealed that in 2023, an additional 549,000 individuals in England were identified as being at risk of developing type 2 diabetes. This brought the overall count of people registered with a GP for non-diabetic hyperglycemia, or pre-diabetes, to 3,615,330. This signifies a substantial increase compared to 3,065,825 in 2022, marking a rise of nearly 20%. Consequently, the escalating incidence of chronic diseases is a primary driver for the growth of the narcotic drug market.
Narcotic Drugs Market Segmentation: How Does The Market Break Down By Category?
The narcotic drugs market covered in this report is segmented –
1) By Drug: Opium, Heroin, Codeine, Oxycodone, Other Drugs
2) By Source: Natural, Semi-Synthetic, Synthetic
3) By Indication: Pain Management, Cough, Diarrhea, Dysentery, Other Indications
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Opium: Raw Opium, Opium Extracts, Opium Derivatives
2) By Heroin: Diacetylmorphine, Heroin Hydrochloride, Heroin Acetate
3) By Codeine: Codeine Phosphate, Codeine Sulfate
4) By Oxycodone: Oxycodone Hydrochloride, Oxycodone Acetaminophen, Controlled-Release Oxycodone
5) By Other Drugs: Fentanyl, Morphine, Hydromorphone, Methadone, Buprenorphine
Narcotic Drugs Market Innovation Trends Shaping Future Development
Major companies within the narcotic drug market are increasingly concentrating on product development and innovation to offer dependable products to their clientele and enhance their market position. For instance, in May 2023, Indivior PLC, a US-based pharmaceutical company, launched OPVEE (nalmefene) nasal spray. This medicine is designed for opioid overdose rescue, effective against natural and synthetic opioids such as fentanyl. It is recommended for the immediate treatment of known or suspected opioid overdoses involving natural or synthetic opioids in adults and pediatric patients 12 years of age and older, especially when respiratory and central nervous system depression are observed.
Narcotic Drugs Market Competitive Overview And Top Companies
Major companies operating in the narcotic drugs market are Pfizer Inc., Johnson and Johnson Limited, AbbVie Inc., Novartis AG, AstraZeneca PLC, Sanofi S.A., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Purdue Pharma LP, Hikma Pharmaceuticals Plc, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Lupin Ltd., Mallinckrodt Pharmaceuticals, Alvogen Inc., Indivior Inc., Impax Laboratories Inc., Collegium Pharmaceutical Inc., Lannett Co Inc., Par Pharmaceutical Inc., West-Ward Pharmaceuticals Corp.
View The Full Narcotic Drugs Market Report:
Narcotic Drugs Market Geographic Spread And Regional Opportunities
Asia-Pacific was the largest region in the narcotic drugs market in 2025. The regions covered in the narcotic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model